Clinical Trials Directory

Trials / Completed

CompletedNCT01247974

Evaluation Of New Onset Postoperative Atrial Fibrillation

Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
439 (actual)
Sponsor
Elutia Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a multi-center, prospective, randomized and controlled clinical trial comparing the safety and efficacy of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation by circumferentially reconstructing the normal pericardial anatomy following isolated, first-time, CABG procedures compared to subjects that do not undergo pericardial closure. This trial will be conducted at up to 20 clinical sites in the U.S.

Detailed description

The objective of this prospective clinical trial is to demonstrate the safety and efficacy of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation by circumferentially reconstructing the normal pericardial anatomy following isolated, first-time, coronary artery bypass grafting (CABG) procedures as compared to subjects who did not undergo pericardial closure. Safety will be established by demonstrating that the composite clinical event rate for the ECM treatment group is not worse than the control group that did not undergo pericardial closure. The efficacy will be established by demonstrating a reduced incidence of new onset postoperative atrial fibrillation in the ECM treatment group as compared to the control group.

Conditions

Interventions

TypeNameDescription
DEVICECorMatrix ECM for Pericardial ClosureCircumferential closure of the pericardium following CABG surgery using the CorMatrix ECM for Pericardial Closure

Timeline

Start date
2010-12-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2010-11-25
Last updated
2023-07-27
Results posted
2015-09-16

Locations

16 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01247974. Inclusion in this directory is not an endorsement.